Item 8.01 Other Information.

Relying on Order for Reporting Relief

On March 4, 2020, the Securities and Exchange Commission ("SEC") issued an order (the "Order") under the Exchange Act of 1934 (the "Exchange Act") extending the deadlines for filing certain reports made under the Exchange Act, including annual reports on Form 10-K, for registrants subject to the reporting obligations under the Exchange Act that have been particularly impacted by the coronavirus disease 2019 ("COVID-19") and which reports have filing deadlines between March 1 and April 30, 2020. Alpha-En Corporation (the "Company") is relying on the Order with respect to its Annual Report on Form 10-K for the year ended December 31, 2019 which was due to be filed with the SEC on or before March 30, 2020.

The Company is relying on the Order due to the reduction in staff, suspension of in-person operations at headquarters and lab facility in Yonkers, New York, and other financial and operational concerns associated with or caused by COVID-19. The Company's business operations are contracted in the greater New York city area, which is currently on "lock-down" orders or "shelter in place" recommendations, including key personnel responsible for assisting the Company in the development of its financial statements. As a result of the travel and work restrictions stemming from the COVID-19 pandemic, the Company is unable to obtain financial records that it needs from its operations to permit the Company to file a timely and accurate Annual Report on Form 10-K for its year ended December 31, 2019 by the prescribed date without undue hardship and expense to the Company. The Company anticipates that it will be able to file its Annual Report on Form 10-K for the year ended December 31, 2019 on or before May 14, 2020.





COVID-19 Risk Factor

The Company is supplementing the risk factors previously disclosed in its most recent periodic reports filed under the Securities Exchange Act of 1934 with the following risk factor:

Our financial and operating performance is adversely affected by the coronavirus pandemic.

The recent outbreak of a strain of coronavirus (COVID-19) in the U.S. has had an unfavorable impact on our business operations. Mandatory closures of businesses, imposed by the federal, state and local governments to control the spread of the virus has resulted in an extended closure of our headquarters and lab facility in Yonkers, New York, which implemented a 75% staff reduction on March 16, 2020 and closed entirely on March 23, 2020, disrupting the operations of our management, business and finance teams. If our headquarters and lab facility are not able to continue operations for an extended period, we cannot assure you that we will continue to have sufficient resources or liquidity to operate our business or that we will be able to continue to advance our technology for the production of highly-pure lithium, or continue our efforts to commercialize such technology. In addition, the COVID-19 outbreak has adversely affected the U.S. economy and financial markets, which may result in a long-term economic downturn that could negatively affect future demand for our technology or our ability to commercialize products based on that technology. The extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments which are highly uncertain and cannot be predicted at the time of the filing of this Form 8-K, but is expected to result in a material adverse impact on our business, results of operations and financial condition.

© Edgar Online, source Glimpses